[
1. Ritter J.M., Flower R.J., Henderson G., Loke Y.K., MacEwan D., Rang H.P. (2019). Rang and Dale’s Farmacology, 98th ed., Elsevier, Churchill Livingstone.
]Search in Google Scholar
[
2. Moffat A.C., Osselton M.D., Widdop B. (2011). Clarke’s Analysis of Drugs and Poisons 4th ed., Pharmaceutical Press, London.
]Search in Google Scholar
[
3. Roche V.F., Zito S.W., Lemke L.T., Williams D.A. (eds) (2019). The Foye’s Principles of Medicinal Chemistry, 8th ed. Lippincott Williams & Wilkins, Philadelphia.
]Search in Google Scholar
[
4. Florence A.T., Attwood D. (2016) Physicochemical Principles of Pharmacy, 6th ed, Pharmaceutical Press, London.
]Search in Google Scholar
[
5. Jašović Gašić M, Vuković O, Pantović M, Cvetić T, Marić Bojović N: Antipsychotics – History of development and field of indication, new wine – old glasses. Psychiatria Danubina, 2012; 24 (Suppl. 3):342–344.
]Search in Google Scholar
[
6. Di L, Kerns EH: Profiling drug - like properties in discovery research. Curr. Opin. Chem. Biol. 2003; 7:402-408.
]Search in Google Scholar
[
7. Brunton L.L., Dandan R.H., Knollmann B.C. (2018). Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 13th ed. The McGraw-Hill Companies, Inc. China.
]Search in Google Scholar
[
8. Kerns E.H., Di L. (2008). Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization. Elsevier, USA.
]Search in Google Scholar
[
9. Hartmann T, Schmitt J: Lipophilicity – beyond octanol/ water: a short comparison of modern technologies. Drug Discov. Today Techn. 2004; 1(4):431-439.
]Search in Google Scholar
[
10. Remko M, Swart M, Bickelhaupt MF: Theoretical study of structure, pKa, lipophilicity, solubility, absorption and polar surface area of some centrally acting antihypertensives. Bioorg. Med. Chem. 2006; 14:1715-1728.
]Search in Google Scholar
[
11. Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherbone B, Cooper I, Platts JA: Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure- activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 2001; 90:749-784.
]Search in Google Scholar
[
12. Lipinski CA: Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol. Toxicol. Met. 2000; 44:235–249.
]Search in Google Scholar
[
13. Odović J, B Marković B, Injac R, Vladimirov S, Karljiković-Rajic K: Correlation between ultra-high performance liquid chromatography-tandem mass spectrometry and reversed-phase thin-layer chromatography hydrophobicity data for evaluation of angiotensin-converting enzyme inhibitors absorption. J. Chromatogr. A. 2012;1258: 94–100.
]Search in Google Scholar
[
14. Odovic J, Markovic B, Vladimirov S, Karljikovic-Rajic K: In Vitro modeling of angiotensin-converting enzyme inhibitor’s absorption with chromatographic retention data and selected molecular descriptors. J. Chromatogr. B. 2014;953: 102-107.
]Search in Google Scholar
[
15. Trbojević J, Odović J, Trbojević-Stanković J, Nešić D, Jelić R: The relationship between angiotensin II receptor antagonists’ bioavailability and molecular properties. Arch Biol Sci. 2016; 68(2): 273-8.10.2298/ABS150915015T
]Search in Google Scholar
[
16. Odovic J, Trbojevic-Stankovic J: Correlation between Angiotensin-converting enzyme inhibitors lipophilicity and protein binding data. Acta Medica Medianae. 2012; 51(4);13-18.
]Search in Google Scholar
[
17. Trbojević-Stanković J, Aleksić M, Odović J: Estimation of Angiotensin-Converting Enzyme Inhibitors Protein Binding Degree Using Chromatographic Hydrophobicity Data. Srp Arh Celok Lek 2015; 143(1-2): 50-55.10.2298/SARH1502050T25845252
]Search in Google Scholar
[
18. Trbojević-Stanković J, Odović J, Jelić R, Nesić D, Stojimirović B: The influence of certain molecular descriptors on fecal elimination of angiotensin II receptor antagonists. Arch Biol Sci. 2015; 67(1):103-109.10.2298/ABS141104011T
]Search in Google Scholar
[
19. Trbojević-Stanković J, Odović J, Jelić R, Nesić D, Stojimirović B: The Effect of the Molecular Properties of Calcium Channel Blockers on Their Elimination Route. Arch Biol Sci. 2015; 67(3): 801-806.10.2298/ABS150127039T
]Search in Google Scholar
[
20. Trbojević J, Odović J, Trbojević-Stanković J, Stojimirović B, Jelić R. The evaluation of angiotensin converting enzyme Inhibitors in renal elimination with selected molecular descriptors. Serb J Exp Clin Res. 2017; 18(2): 119-123.10.1515/sjecr-2016-0100
]Search in Google Scholar
[
21. Berić J, Jelić R, Nešić D, Trbojević-Stanković J, Odović J: Estimation of plasma protein binding of selected antipsychotics using computed molecular properties. Arch Biol Sci. 2017; 69(31): 463-468
]Search in Google Scholar
[
22. Tetko IV. Virtual Computational Chemistry Laboratory. www.vcclab.org URL: http://www.vcclab.org/lab/alogps/ (date accessed 25.12.2019.)
]Search in Google Scholar
[
23. Molinspiration free Property Calculation Service from Bratislava University www.molinspiration.com URL: https://www.molinspiration.com/cgi-bin/propertie (date accessed 25.12.2019.)
]Search in Google Scholar
[
24. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017 www.drugbank.ca Available from URL: https://www.drugbank.ca/unearth/q?utf8=%E2%9C%93&searcher=drugs&query=antipsychotics (date accessed 25.12.2019.)10.1093/nar/gkx1037575333529126136
]Search in Google Scholar
[
25. Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherbone B, Cooper I, Platts JA: Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure- activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 2001; 90:749-784.
]Search in Google Scholar
[
26. Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I: Rate-Limited Steps of Human Oral Absorption and QSAR Studies. Pharmac. Res. 2002;, 19:1446-1457.
]Search in Google Scholar
[
27. Mannhold R, Poda GI, Tetko I: Calculation of molecular lipophilicity: state-of-the-art and comparison of log P methods on more than 96,000 compounds. J.Pharm. Sci. 2009; 98: 861–893.
]Search in Google Scholar
[
28. Mandić Z. (ed) (2012). Physico-Chemical Methods in Drug Discovery and Development IAPC Publishing, Zagreb, Croatia.10.5599/obp.7.0
]Search in Google Scholar
[
29. Asuero AG, Sayago A, Gonzalez AG: The correlation coefficient: An overview. Crit. Rev. Anal. Chem. 2006; 36:41-59.
]Search in Google Scholar
